Jubilant Life has 3 broad segment Pharmaceuticals, Life Science Ingredients & Drug Discovery. Spend time on the attched images to look at sub segments & revenue contribution. Please refer this images while reading furthur (2/10)
Radiopharmaceuticals:
Specializes in cardiology, pulmonology, oncology and endocrinology as well as bone, brain and renal imaging. USFDA approved manufacturing facility at Kirkland, Montreal
(3/10)
Specializes in cardiology, pulmonology, oncology and endocrinology as well as bone, brain and renal imaging. USFDA approved manufacturing facility at Kirkland, Montreal
(3/10)
Some products with 100% market share
1. MAA (lung imaging)
2. Draxlmage DTPA (renal imaging)
3. HICON sodium Iodine-131 (thyroid)
Increasing market share of RUBY‐FILL-Growth driver (4/10)
1. MAA (lung imaging)
2. Draxlmage DTPA (renal imaging)
3. HICON sodium Iodine-131 (thyroid)
Increasing market share of RUBY‐FILL-Growth driver (4/10)
Allergy Therapy Business:
Number 2 player in the allergenic extract market in the US. USFDA approved manufacturing facilities at Spokane facility (5/10)
Number 2 player in the allergenic extract market in the US. USFDA approved manufacturing facilities at Spokane facility (5/10)
Contract Manufacturing Business – Sterile Injectables and Non‐Sterile Products:
Sterile injectables 80% & Non‐sterile 20%.
Long‐term relationships with our top 10 customers.
USFDA approved manufacturing facilities located in Spokane, Washington and Montreal, Canada. (6/10)
Sterile injectables 80% & Non‐sterile 20%.
Long‐term relationships with our top 10 customers.
USFDA approved manufacturing facilities located in Spokane, Washington and Montreal, Canada. (6/10)
API Business:
80% of commercialized portfolio is in lifestyle driven therapeutic areas such as CVS (cardiovascular system), CNS (central nervous system ), anti‐infective and non‐communicable diseases.
API facility at Nanjangud, Karnataka. (7/10)
80% of commercialized portfolio is in lifestyle driven therapeutic areas such as CVS (cardiovascular system), CNS (central nervous system ), anti‐infective and non‐communicable diseases.
API facility at Nanjangud, Karnataka. (7/10)
Solid Dosage Formulations Business:
Manufacturing facility at Salisbury, US and Roorkee, India.
1 player in 4 products with over 45% share in each of the three products.
Amongst top 3 players in another 2 products (8/10)
Manufacturing facility at Salisbury, US and Roorkee, India.
1 player in 4 products with over 45% share in each of the three products.
Amongst top 3 players in another 2 products (8/10)
Specialty Intermediates & Nutritional Products:
Specialty Intermediates includes Pyridines, Picolines, Cyanopyridines, Piperidine.
Nutritional products comprises of Vitamins, Animal Nutrition & Human Nutrition.
Vitamin B3: Global share 16%,
Vitamin B4: India share 64% (9/10)
Specialty Intermediates includes Pyridines, Picolines, Cyanopyridines, Piperidine.
Nutritional products comprises of Vitamins, Animal Nutrition & Human Nutrition.
Vitamin B3: Global share 16%,
Vitamin B4: India share 64% (9/10)